Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Corynebacterineae Stories

2012-06-12 02:26:25

SAN FRANCISCO, June 12, 2012 /PRNewswire/ -- Medizone International, Inc. (The Company) (MZEI:OB) (MZEI:QB) announced today that in achieving 100% kill rates with TB in three successive trials, it had achieved another important milestone in its understanding of the antimicrobial limits of its recently launched disinfection technology, AsepticSure(TM). Dr. Michael E Shannon, President of Medizone International, stated, "With one third of the world's population currently infected with...

2012-06-08 05:20:54

(Ivanhoe Newswire) -- In 2010 the World Health Organization (WHO) estimated there were 290,000 cases of multi-drug resistant tuberculosis globally. Now a new medication attempts to slash those numbers. Delamanid, a nitro-dihydro-imidazooxazole derivative, is a new medication that inhibits mycolic acid synthesis (long fatty acids found in the cell walls of the mycolata taxon) and has shown potent in vitro (half living-in a Petri dish) and in vivo (living in the body) activity against drug...

2012-05-31 06:28:19

BRONX, N.Y., May 31, 2012 /PRNewswire-USNewswire/ -- The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium...

2012-05-16 06:26:50

WESTMINSTER, Colo., May 16, 2012 /PRNewswire/ -- GeneThera, Inc. (OTCQB: GTHR) announced today that Applied Genetics, GeneThera's majority owned subsidiary, signed a research and test validation agreement with Universidad National Autonoma de Mexico (UNAM). Scope of the agreement is to validate GeneThera proprietary Johne's disease (JD) HerdCheck Field Collection System (FCS) Molecular Assay in Mexico. Dr. Tony Milici, interim president of Applied Genetics and CEO of GeneThera, stated, "This...

2012-02-15 21:39:34

According to the World Health Organization (WHO), one-third of the world's population is currently infected with tuberculosis bacteria. The bacteria is incredibly resistant to treatment, and despite its prevalence, very little is known about why it is so stress tolerant. But, researchers at the University of Pittsburgh have been developing a new way of culturing tuberculosis bacteria, which could lead to new insights and treatments. "This is a significant step forward in TB research," said...

2012-01-25 08:30:00

WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/ -- GeneThera, Inc. (OTCQB: GTHR) announced today that it has acquired a majority ownership of Applied Genetics, a molecular diagnostic company based in Monterrey, Mexico. Applied Genetics is a molecular diagnostic company that focuses on commercializing molecular testing for Johne's disease in Mexico. This acquisition is part of a broader strategy aimed at quickly initiating Applied Genetics revenue-generating operation. Dr. Tony...

2011-12-15 17:17:47

Findings could lead to more effective treatment for global disease A new study led by Harvard School of Public (HSPH) researchers provides a novel explanation as to why some tuberculosis cells are inherently more difficult to treat with antibiotics. The discovery, which showed that the ways mycobacteria cells divide and grow determine their susceptibility to treatment with drugs, could lead to new avenues of drug development that better target tuberculosis cells. The study appears...

2011-11-30 14:53:11

A University of Adelaide scientist says much more could be done to predict the likelihood and spread of serious disease - such as tuberculosis (TB) or foot-and-mouth disease - in Australian wildlife and commercial stock. Professor Corey Bradshaw and colleagues have evaluated freely available software tools that provide a realistic prediction of the spread of disease among animals. They used a combination of models to look at the possible spread of TB among feral water buffalo in the...

2011-11-16 23:37:14

It's estimated that nearly one-third of the world's population–more than two billion people–are infected with Mycobacterium tuberculosis. According to the World Health Organization, 5 to 10 percent of infected people eventually develop active tuberculosis and can transmit the bacterium to others. Almost two million die from the disease each year. But the current treatment regimen for the disease is long and arduous, making patient compliance difficult. As a result, some strains of...

2011-10-04 09:27:14

The bacterium that causes tuberculosis has a unique molecule on its outer cell surface that blocks a key part of the body´s defense. New research suggests this represents a novel mechanism in the microbe´s evolving efforts to remain hidden from the human immune system. Researchers found that the TB bacterium has a molecule on its outer surface called lipomannan that can stop production of an important protein in the body´s immune cells that helps contain TB infection and...


Latest Corynebacterineae Reference Libraries

72_0ab04c9452ae9b3c6ae51f6deb1bcc35
2011-04-25 16:19:14

Mycobacterium tuberculosis (MTB) is a pathogenic bacterial species in the genus Mycobacterium and the causative agent of most cases of tuberculosis. Robert Koch first discovered it in 1882 and that it had an unusual, waxy coating on the cell surface which makes them impossible to Gram stain. M. tuberculosis is highly aerobic and requires high levels of oxygen. It generally infects the respiratory system of mammals. Tuberculin skin test, acid-fast stain, and chest radiographs are the most...

0_b33ceb9bb58e871b533817f5a6385ba1
2011-04-25 15:56:48

Mycobacterium smegmatis is 3.0 to 5.0 µm long with a bacillus shape, an acid-fast bacterial species in the phylum Actinobacteria. It can be stained by Ziehl-Neelsen method and the auramine-rhodamine fluorescent method. It was first reported in 1884. Alvarez and Tavel found organisms similar to Lustgarten, who first discovered Mycobacterium. This organism was later named M. smegmatis. It is considered a non-pathogenic microorganism although, in rare cases, it can cause disease. M....

0_da8e53266fdcbd2830a775ec887963be
2011-04-25 15:36:41

Mycobacterium leprae, mostly found in warm tropical countries, is a bacterium that causes leprosy (Hansen's disease). It is an intracellular, pleomorphic, acid-fast bacterium. M. leprae is an aerobic rod-shaped surrounded by the characteristic waxy coating unique to mycobacteria tuberculosis. Due to its thick waxy coating, M. leprae stains with a carbol fuscin rather than with the traditional Gram stain. Gerhard Armauer Hansen first discovered it in 1873. It was the first bacterium to be...

45_255d6ba67dfe6f32b9c7c31f338bf912
2011-04-18 22:11:24

Mycobacterium bovis is a slow-growing, aerobic bacterium and the causative agent of tuberculosis in cattle. Similar to M. tuberculosis, M. bovis can jump the species barrier and cause tuberculosis in humans. It is estimated that M. bovis was responsible for more losses among farm animals than all other diseases combined in the first half of the 20th century. Infection happens after bacterium is ingested. It is generally transmitted to humans via infected milk. Actual human infections are...

0_a16d5f8c7a5fecb318cce3c15433fb95
2011-04-15 14:19:47

Corynebacterium diphtheriae is a pathogenic bacterium that causes diphtheria. It was discovered in 1884. There are four subspecies C. diphtheriae mitis, C. diphtheriae intermedius, C. diphtheriae gravis, and C. diphtheriae belfanti. They all are a little bit different in their colonial morphology and biochemical properties such as the ability to metabolize certain nutrients. The diphtheria toxin gene is encoded by a bacteriophage which is found in toxigenic strain. A gram stain is...

More Articles (5 articles) »